May 2023 in “Zenodo (CERN European Organization for Nuclear Research)” In this review, researchers synthesized current knowledge on Eclipta alba (Bhringaraja) from traditional Ayurvedic texts and scientific literature, reporting its wide range of pharmacological properties, including hepatoprotective, antioxidant, antimicrobial, and anticancer effects, attributed to its chemical compounds like wedelolactone.
May 2023 in “GSC Advanced Research and Reviews” This review highlights the diverse pharmacological properties of Eclipta alba, often used traditionally in Asian medicine, detailing its hepatoprotective, hair growth promoting, antidiabetic, and other therapeutic activities linked to its chemical compounds such as wedelolactone.
June 2025 in “Universities Journal of Phytochemistry and Ayurvedic Heights” This study evaluated the wedelolactone content and antimicrobial activity of Eclipta alba and Wedelia chinensis extracts, finding a potential relationship between the concentration of wedelolactone and their in vitro antimicrobial effects against several pathogenic bacteria and yeast.
83 citations
,
October 2012 in “International Journal of Oncology” In this in vitro study, wedelolactone induced selective apoptosis in prostate cancer cells by inhibiting 5-Lox activity, suggesting it may have potential as a treatment for prostate cancer.
January 2000 in “Time to knit” This article describes the extraction and characterization method for wedelolactone from Eclipta alba but presents no new clinical results.